ENFN
Enfusion, Inc. (ENFN) Risks & Opportunities Analysis (2026)
Overall Score
Balance Sheet Risk
ENFN maintains a strong liquidity position with a current ratio of 3.42 and cash ratio of 1.99.
Leverage remains low with debt-to-equity at 0.28 and net debt-to-EBITDA at -5.55, indicating net cash.
No material near-term balance sheet stress is evident from the latest metrics.
Profitability Risk
Profitability remains thin, with net profit margin at 1.40% and operating margin at 3.05%.
Return metrics are still modest, including ROE of 4.45% and ROIC of 1.93%.
High valuation multiples leave limited room for execution misses if margins do not improve.
Cash Flow Risk
Cash generation is positive, with free cash flow yield at 3.04% and operating cash flow margin at 17.20%.
Capital intensity appears manageable, as capex is only 10.48% of operating cash flow.
Cash conversion remains healthy, supported by a cash conversion cycle of 53.0 days.
Valuation Risk
Valuation remains elevated at 4.89x EV/sales and 32.86x price-to-free-cash-flow.
Earnings-based multiples are extremely high, with P/E at 572.34x, reflecting limited current earnings power.
The stock still appears priced for meaningful future growth and margin expansion.
Growth Opportunity
Revenue per share of 2.19 and gross margin of 67.82% suggest a solid software-style economics base.
Operating leverage could improve if the company scales revenue faster than SG&A, which is still 51.51% of revenue.
However, current profitability remains too low to classify growth as a strong near-term catalyst.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Enfusion, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

